Výsledky vyhledávání - Addiction
-
41Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons. Results from an EMCDDA trendspotter study. Lisboa, European Monitoring Centre for Drugs and Drug Addiction, 2021, 38 p.Umístění: SIIS Archivo
-
42Balancing access to opioid substitution treatment with preventing the diversion of opioid substitution medications in Europe: challenges and implications. Serie: EMCDDA Technical Report, Lisboa, European Monitoring Centre for Drugs and Drug Addiction, 2021, 50 p.Umístění: SIIS Archivo
-
43European Monitoring Centre for Drugs and Drug Addiction, An analysis of drugs in used syringes from sentinel European cities. Results from the SCAPE project, 2018 and 2019. Serie: Technical Report, Luxemburgo, Publications Office of the European Union, 2021, 47 p.Umístění: SIIS Archivo
-
44European Monitoring Centre for Drugs and Drug Addiction, EMCDDA operating guidelines for the risk assessment of new psychoactive substances. Luxemburgo, Publications Office of the European Union, 2020, 21 p.Umístění: SIIS Archivo
-
45The ESPAD Group, ESPAD Report 2019. Results from the European School Survey Project on Alcohol and other Drugs. Lisboa, European Monitoring Centre for Drugs and Drug Addiction, 2020, 136 p.Umístění: SIIS Archivo
-
46European Monitoring Centre for Drugs and Drug Addiction, Wastewater analysis and drugs. A European multi-city study. Serie: Perspectives on Drugs, Lisboa, European Monitoring Centre for Drugs and Drug Addiction, 2020, 14 p.Umístění: SIIS Archivo
-
47European Monitoring Centre for Drugs and Drug Addiction, European Drug Report 2020. Trends and Developments. Luxemburgo, Publications Office of the European Union, 2020, 88 p.Umístění: SIIS Archivo
-
48European Monitoring Centre for Drugs and Drug Addiction, Impact of COVID-19 on patterns of drug use and drug-related harms in Europe. Lisboa, European Monitoring Centre for Drugs and Drug Addiction, 2020, 27 p.Umístění: SIIS Archivo
-
49Evans-Brown, M., et al., EMCDDA operating guidelines for the European Union Early Warning System on new psychoactive substances. Lisboa, European Monitoring Centre for Drugs and Drug Addiction, 2019, 27 p.Umístění: SIIS Archivo
-
50Methamphetamine in Europe: EMCDDA-Europol threat assessment. Lisboa, European Monitoring Centre for Drugs and Drug Addiction, 2019, 23 p.Umístění: SIIS Archivo
-
51EU drug markets. Impact of Covid-19. European Monitoring Centre for Drugs and Drug Addiction, Europol, 2020, 31 p.Umístění: SIIS Archivo
-
52Thierry, J.P., Reynaud, M., Addictions: la révolution de l'e-santé pour la prévention, le diagnostic et la prise en charge. París, Mission Interministérielle de Lutte contre les Drogues et les Conduites Addictives (MILDECA), 2019, 104 p.Umístění: SIIS Archivo
-
53European Monitoring Centre for Drugs and Drug Addiction, Drug-related infectious diseases in Europe. Update from the EMCDDA expert network. Serie: Technical report, Luxemburgo, Publications Office of the European Union, 2020, 27 p.Umístění: SIIS Archivo
-
54Impact of COVID-19 on drug services and help-seeking in Europe. Serie: EMCDDA Trendspotter Briefing, Lisboa, European Monitoring Centre for Drugs and Drug Addiction, 2020, 21 p.Umístění: SIIS Archivo
-
55EMCDDA special report COVID-19 and drugs. Drug supply via darknet markets. Lisboa, European Monitoring Centre for Drugs and Drug Addiction, 2020, 22 p.Umístění: SIIS Archivo
-
56Castaño, G.A., et al., Toward the design and validation of a scale to assess Amotivational Syndrome in Chronic Marijuana Users (ESATHC). International Journal of Mental Health and Addiction, vol. 18, n. 2, 2020, p. 305-313.Umístění: SIIS Archivo
-
57European Monitoring Centre for Drugs and Drug Addiction, Drug-related hospital emergency presentations in Europe: update from the Euro-DEN Plus expert network. Serie: Technical Report, Luxemburgo, Publications Office of the European Union, 2020, 35 p.Umístění: SIIS Archivo
-
58Hayes, C.J., et al., Impact of opioid dose escalation on the development of substance use disorders, accidents, self-inflicted injuries, opioid overdoses and alcohol and non-opioid drug-related overdos... Addiction, preprint, 2020, p. 1-15.Umístění: SIIS Archivo (R.696)
-
59Kiluk, B.D., et al., et al., What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?. Addiction, preprint, 2019, p. 9-15.Umístění: SIIS Archivo (R.696)
-
60Pardo, B., et al., Monitoring and evaluating changes in cannabis policies: insights from the Americas. Serie: Technical Report, Lisboa, European Monitoring Centre for Drugs and Drug Addiction, 2020, 76 p.Umístění: SIIS Archivo